Although these results were based on low SPC counts, previous findings of elevated first primary risks at the breast and prostate in male BRCA2 PV carriers, colorectal cancer in female BRCA1 PV carriers, and pancreatic cancer in female BRCA2 PV carriers33 suggest these associations may be true. This evidence concerns the gene BRCA2 and familial pancreatic carcinoma.